These effects, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the thought of targeting ACKR3 as a unique method to modulate the opioid program, which could open new therapeutic avenues for opioid-related disorders. (2) The medical doctor has been https://richardv825rqr1.wikiadvocate.com/user